KRRO - NASDAQ

Korro Bio, Inc.

KRRO·NASDAQ

$11.08

+2.1%

HealthcareBiotechnology

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$110.28M

EPS-12.4800

P/E Ratio-0.89

Earnings Date08/11/2026

krro

Operating Expenses

Last Annual Value

89.45M

3-Year CAGR

15%

5-Year CAGR

10-Year CAGR

19%

Adjust for Inflation

Korro Bio, Inc. Competitors Analysis of Operating Expenses

KRRO · NASDAQ

Company	Operating Expenses	CAGR 3Y	CAGR 5Y	CAGR 10Y
Korro Bio, Inc. NASDAQ:KRRO	89.45M	1.9%	-1.0%	N/A
Alto Neuroscience, Inc. NYSE:ANRO	65.70M	20.2%	40.2%	N/A
Aura Biosciences, Inc. NASDAQ:AURA	112.79M	10.5%	26.2%	N/A
Larimar Therapeutics, Inc. NASDAQ:LRMR	172.50M	60.5%	27.9%	11.7%
Altimmune, Inc. NASDAQ:ALT	94.53M	-0.6%	-1.4%	19.1%
MBX Biosciences, Inc. Common Stock NASDAQ:MBX	98.06M	40.6%	N/A	N/A
Quantum-Si incorporated NASDAQ:QSI	93.75M	-5.7%	-0.7%	N/A
RAPT Therapeutics, Inc. NASDAQ:RAPT	136.10M	2.3%	13.3%	N/A
Rocket Pharmaceuticals, Inc. NASDAQ:RCKT	217.49M	-5.7%	5.4%	17.9%
LB Pharmaceuticals Inc Common Stock NASDAQ:LBRX	30.40M	38.8%	N/A	N/A
Annexon, Inc. NASDAQ:ANNX	212.72M	14.0%	10.2%	N/A

Korro Bio, Inc. Fair Value Envelope

KRRO · NASDAQ

Our analysis suggests that KRRO has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $11.08, this represents a potential HIDDEN relative to our calculated worth for Korro Bio, Inc..

HIDDEN

Intrinsic Value

Current Price: $11.08

Related Guides

Blog Categories

Continue your KRRO research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.